Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Nov 8, 2021

30870_dirs_2021-11-08_da7ff841-c62e-4d1c-9708-899f82e4a674.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-11-08

Reporting Person: GAGE L PATRICK (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-08 Common Stock M 22302 $4.02 Acquired 51234 Direct
2021-11-08 Common Stock S 22302 $41.3338 Disposed 28932 Direct
2021-11-08 Common Stock M 4166 $5.46 Acquired 33098 Direct
2021-11-08 Common Stock S 4166 $41.3338 Disposed 28932 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-08 Non-Qualified Stock Option (right to buy) $4.02 M 22302 Disposed 2023-01-02 Common Stock (22302) Direct
2021-11-08 Non-Qualified Stock Option (right to buy) $5.46 M 4166 Disposed 2022-05-22 Common Stock (4166) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1850 Indirect

Footnotes

F1: Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.